Related Experiment Video
Updated: Aug 12, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome
P S Davies1, S Evans, S Broomhead
1School of Human Movement Studies, Faculty of Health, Queensland University of Technology, Brisbane, Australia.
Insights
Growth hormone treatment in children with Prader-Willi syndrome significantly reduced body fat and increased height velocity. Further trials are recommended to explore optimal dosages for this condition.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Growth Hormone Therapy
Background:
- Prader-Willi syndrome is a complex genetic disorder affecting multiple body systems.
- Children with Prader-Willi syndrome often exhibit growth deficiencies and abnormal body composition.
Purpose of the Study:
- To assess the impact of growth hormone (GH) administration on stature, body weight, and body composition in children with Prader-Willi syndrome.
- To evaluate changes in anthropometric measurements and body fat percentage following GH treatment.
Main Methods:
- A study involving 25 children aged 4-10 years with Prader-Willi syndrome.
- Measurements of height, weight, and skinfold thickness recorded at baseline and after six months of daily subcutaneous GH injections.
- Body composition assessed using total body water measurements with stable isotopes.
Main Results:
- Significant reduction in body fat percentage observed post-GH treatment.
- Height velocity doubled during the six-month treatment period.
- Body weight SDS remained unchanged, while skinfold thickness decreased significantly.
Conclusions:
- Growth hormone treatment shows promising benefits for children with Prader-Willi syndrome.
- Results support further prolonged trials and investigation into varied GH dosage regimens.
- GH therapy may be a valuable intervention for improving body composition and growth in this population.
Aims:
To evaluate the effect of the administration of growth hormone on stature, body weight, and body composition in children aged between 4 and 10 years with Prader-Willi syndrome.
Methods:
Height, weight, and skinfold thickness were recorded in 25 children using standard anthropometric techniques at recruitment, and six months later, shortly before the start of daily subcutaneous injections of growth hormone. Body composition was assessed via a measurement of total body water using stable isotopes. Measurements were repeated at the end of the six months of growth hormone administration. Measurements of height, weight, and skinfold thickness were expressed as standard deviation scores (SDSs).
Results:
There was a significant reduction in the percentage of body fat after growth hormone treatment; height velocity doubled during treatment; body weight did not change significantly when expressed as an SDS. Skinfold thickness at both the triceps and subscapular site decreased in absolute terms and when expressed as an SDS.
Conclusions:
These results indicate sufficient potential benefit to justify a more prolonged trial of growth hormone treatment and an exploration of different dosage regimens in children with Prader-Willi syndrome.
More Related Videos
05:04Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
08:03Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
Published on: November 4, 2025
Related Concept Videos
Polygenic Traits
Nature and Nurture
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Cellular Adaptation II: Hypertrophy